A detailed history of Signal Point Asset Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Signal Point Asset Management, LLC holds 6,891 shares of EXAS stock, worth $400,436. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,891
Previous 6,753 2.04%
Holding current value
$400,436
Previous $285,000 64.56%
% of portfolio
0.12%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$42.43 - $70.83 $5,855 - $9,774
138 Added 2.04%
6,891 $469,000
Q2 2024

Jul 22, 2024

SELL
$41.33 - $74.26 $5,620 - $10,099
-136 Reduced 1.97%
6,753 $285,000
Q1 2024

Apr 11, 2024

BUY
$56.27 - $73.77 $20,876 - $27,368
371 Added 5.69%
6,889 $475,000
Q4 2023

Jan 17, 2024

BUY
$59.06 - $75.72 $5,433 - $6,966
92 Added 1.43%
6,518 $482,000
Q3 2023

Oct 13, 2023

BUY
$65.94 - $99.04 $989 - $1,485
15 Added 0.23%
6,426 $438,000
Q2 2023

Jul 12, 2023

SELL
$62.68 - $95.05 $7,458 - $11,310
-119 Reduced 1.82%
6,411 $601,000
Q1 2023

Apr 14, 2023

BUY
$47.19 - $70.77 $1,793 - $2,689
38 Added 0.59%
6,530 $442,000
Q4 2022

Jan 26, 2023

BUY
$30.35 - $53.15 $197,032 - $345,049
6,492 New
6,492 $0
Q3 2022

Oct 27, 2022

BUY
$31.97 - $49.37 $6,681 - $10,318
209 Added 3.4%
6,364 $206,000
Q2 2022

Jul 25, 2022

SELL
$35.61 - $76.23 $15,169 - $32,473
-426 Reduced 6.47%
6,155 $242,000
Q1 2022

May 09, 2022

BUY
$57.56 - $82.54 $45,472 - $65,206
790 Added 13.64%
6,581 $460,000
Q4 2021

Jan 31, 2022

BUY
$72.5 - $100.68 $419,847 - $583,037
5,791 New
5,791 $450,000
Q1 2020

Apr 23, 2020

SELL
$37.9 - $104.44 $263,973 - $727,424
-6,965 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$77.66 - $99.74 $540,901 - $694,689
6,965 New
6,965 $644,000
Q3 2019

Oct 18, 2019

SELL
$90.37 - $122.49 $523,874 - $710,074
-5,797 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $64,447 - $84,988
-720 Reduced 11.05%
5,797 $684,000
Q1 2019

May 01, 2019

SELL
$61.98 - $96.5 $42,456 - $66,102
-685 Reduced 9.51%
6,517 $565,000
Q4 2018

Jan 22, 2019

BUY
$56.04 - $82.66 $85,124 - $125,560
1,519 Added 26.73%
7,202 $454,000
Q3 2018

Oct 31, 2018

SELL
$48.29 - $80.6 $35,010 - $58,434
-725 Reduced 11.31%
5,683 $449,000
Q2 2018

Jul 26, 2018

SELL
$37.84 - $69.96 $68,755 - $127,117
-1,817 Reduced 22.09%
6,408 $383,000
Q1 2018

Apr 24, 2018

BUY
$39.82 - $57.53 $327,519 - $473,184
8,225 New
8,225 $332,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Signal Point Asset Management, LLC Portfolio

Follow Signal Point Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Point Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Point Asset Management, LLC with notifications on news.